REGN846 (SAR302352)

SAR302352 · Regeneron Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for REGN846 (SAR302352), covering 2012-06-01 to 2012-06-01. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability Study of REGN846 (SAR302352) in Healthy Volunteers [Phase 1]